Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 968-968
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 30
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
Stefano Ciardullo, Michela Vergani, Gianluca Perseghin
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5597-5597
Open Access | Times Cited: 31
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
Cristina Bică, Roxana Adriana Stoica, Teodor Salmen, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1136-1136
Open Access | Times Cited: 28
Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes
Raghid Reyadh Altalebi, Hany Akeel Al-Hussaniy, Zahraa Salam Al-Tameemi, et al.
Journal of Medicine and Life (2023) Vol. 16, Iss. 1, pp. 42-47
Open Access | Times Cited: 23
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
M H Miran Beygi, Salma Ahi, Samaneh Zolghadri, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2220-2220
Open Access | Times Cited: 13
Vascular complications of diabetes: A narrative review
Yongxia Lu, Wei Wang, Jingyu Liu, et al.
Medicine (2023) Vol. 102, Iss. 40, pp. e35285-e35285
Open Access | Times Cited: 21
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera, Javier Uribe, Nixa Olvares, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 4, pp. 101501-101501
Open Access | Times Cited: 6
Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes
Sahar Samimi, Sahar Rajabzadeh, Soghra Rabizadeh, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 17
Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study
Niloofar Deravi, Fatemeh Dehghani Firouzabadi, Fatemeh Moosaie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Increased risk for microvascular outcomes in NAFLD—A nationwide, population‐based cohort study
Thomas Ebert, Linnea Widman, Peter Stenvinkel, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 2, pp. 216-227
Open Access | Times Cited: 9
A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis
Miguel Suárez, Raquel Martínez, Ana María Torres, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 9, pp. 3801-3809
Closed Access | Times Cited: 8
From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
Bruno Basil, B. Myke-Mbata, Onyinye Ezinne Eze, et al.
Clinical Diabetes and Endocrinology (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 2
Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
Marcin Kosmalski, Józef Drzewoski, Izabela Szymczak-Pajor, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2253-2253
Open Access | Times Cited: 11
Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Myrsini Orfanidou, Charikleia Ntenti, Kleo Evripidou, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1148-1148
Open Access | Times Cited: 5
Triglyceride to high-density lipoprotein cholesterol ratio as a marker of non-alcoholic fatty liver disease in type 2 diabetes
Robert Dwitama Adiwinoto, Agung Pranoto, Titong Sugihartono, et al.
International Journal of Public Health Science (IJPHS) (2024) Vol. 13, Iss. 3, pp. 1039-1039
Open Access | Times Cited: 1
FPS-ZM1 attenuates the deposition of lipid in the liver of diabetic mice by sterol regulatory element binding protein-1c
Mengshu Zhang, Wanwan Zhao, Zhen Zhang, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Risk Scores for Prediction of Major Cardiovascular Events in Non-Alcoholic Fatty Liver Disease: A No Man’s Land?
Liliana Gheorghe, Roxana Nemțeanu, Andreea Clim, et al.
Life (2023) Vol. 13, Iss. 4, pp. 857-857
Open Access | Times Cited: 3
Nonalcoholic fatty liver disease and diabetes
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, et al.
World Journal of Diabetes (2022) Vol. 13, Iss. 9, pp. 668-682
Open Access | Times Cited: 5
From cause to consequence: Insights into incident diabetes mellitus after hepatic steatosis
Manik Aggarwal, Christina C. Lindenmeyer
Clinical Liver Disease (2023) Vol. 21, Iss. 2, pp. 41-46
Open Access | Times Cited: 2
Circ_0004535/miR-1827/CASP8 network involved in type 2 diabetes mellitus with nonalcoholic fatty liver disease
Min Li, Ai Zeng, Xinle Tang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Increasing Adiposity Is Associated With QTc Interval Prolongation and Increased Ventricular Arrhythmic Risk in the Context of Metabolic Dysfunction: Results From the UK Biobank
Kiran Haresh Kumar Patel, Xinyang Li, Xiao Xu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Clinical Research on Type 2 Diabetes: A Promising and Multifaceted Landscape
Fernando Gómez-Peralta, Cristina Abreu
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6007-6007
Open Access | Times Cited: 3
Relationship between fibrosis-4 score and microvascular complications in patients with type 2 diabetes mellitus
Beril Turan Erdoğan, Abbas Ali Tam, Hüsniye Başer, et al.
Arab Journal of Gastroenterology (2024) Vol. 25, Iss. 3, pp. 269-274
Closed Access
Protective effect of β-sitosterol against high-fructose diet-induced oxidative stress, and hepatorenal derangements in growing female sprague-dawley rats
Nontobeko M. Gumede, Busisani W. Lembede, Pilani Nkomozepi, et al.
Laboratory Animal Research (2024) Vol. 40, Iss. 1
Open Access
Az ómega-3 zsírsavak jelentősége a nem alkoholos zsírmájbetegség kezelésében
Rebeka Anna Makó, Anna Egresi, Anna Blázovics, et al.
Orvosi Hetilap (2023) Vol. 164, Iss. 33, pp. 1294-1299
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top